ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the subsidy status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the subsidy recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 30 Sep 2021
Last Updated on 30 Sep 2021
A- A+
Guidance Recommendation

The Ministry of Health’s MTAC has not recommended subsidising cochlear implants in the treatment of adults with single-sided deafness (SSD).

Subsidy status

Cochlear implants are not recommended for subsidy in adults with the abovementioned indications.

Cochlear implants for treating adults with single-sided deafness (SSD)